Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen taking Mounjaro, a few straightforward habits make a real difference: inject once weekly on a consistent day, keep your pen refrigerated, prioritise protein and hydration alongside a reduced-calorie diet, and contact your prescriber if side effects feel unmanageable. Mounjaro (tirzepatide) is a prescription-only medicine, and getting these basics right is part of what clinical supervision is there to support. This page walks through the practical things worth knowing, drawn from the licensed guidance and clinical evidence.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Choose a day of the week that works for your schedule and keep it. Mounjaro is a once-weekly injection, and a consistent gap between doses matters more than most people realise — the pharmacokinetics of tirzepatide are designed around a seven-day rhythm. Missing a day here or there can affect tolerability at the next dose step.
Before injecting, take the pen out of the fridge and let it reach room temperature for a few minutes. Inject into the abdomen, thigh or upper arm, rotating the site each week to avoid skin reactions building up in one spot. Wipe the chosen area with an alcohol swab first, let it dry, then press the pen firmly to the skin and hold it for the count instructed in the leaflet.
One misconception worth clearing up gently: some people assume the injection needs to go into a vein, like a blood draw. It doesn't. Mounjaro is a subcutaneous injection, meaning it goes just under the skin into the fatty tissue, not into muscle and not into a vein. The KwikPen is designed so that technique is almost foolproof once you've read the instructions, and our tips for taking Mounjaro cover positioning and common first-time worries in more detail, alongside our guide to what to do when on Mounjaro.
Dispose of used pens in a sharps container, never in a household bin. The full guide to taking Mounjaro has more on safe disposal if you need it.
Mounjaro works alongside a reduced-calorie diet and increased physical activity, the licensed indication specifies both, and trial results like those from SURMOUNT-1, published in the New England Journal of Medicine, were achieved with those lifestyle components in place alongside treatment.
Because tirzepatide reduces appetite significantly, it can become easy to eat too little, particularly of the right things. The practical priorities: enough protein at each meal (it helps preserve muscle mass and keeps you feeling fuller for longer), consistent hydration throughout the day, and fibre from vegetables, legumes and wholegrains to support gut motility. Constipation is a common side effect, and adequate fibre and fluid genuinely help.
There are no hard food bans, but high-fat meals and alcohol can worsen nausea, especially in the early weeks or after a dose increase. Smaller, more frequent meals tend to sit better than large ones. The foods and habits to avoid on Mounjaro page goes into more detail on specific triggers.
Your prescriber is the right person to tailor nutritional guidance to your situation. Personal targets are outside the scope of this page, but NHS Better Health's weight-loss guidance is a practical starting point for general principles.
Nausea, indigestion, constipation, diarrhoea and fatigue are the most common effects when starting Mounjaro or moving up a dose. They're usually mild to moderate and settle within a week or two as your body adjusts. Eating smaller portions, avoiding greasy food and staying hydrated help most people through the early weeks.
A few symptoms need prompt medical attention. Severe stomach pain that spreads to the back (with or without vomiting) can be a sign of pancreatitis, an infrequent but serious condition. The MHRA issued a Drug Safety Update on this in January 2026 following a review of GLP-1 medicines as a class. If that kind of pain develops, stop treatment and get urgent help. Signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing, hives) also warrant calling 999 or going to A&E.
Other symptoms to flag to your prescriber rather than waiting: gallbladder-type pain (right-side, upper abdomen, sometimes after eating), signs of dehydration from prolonged vomiting or diarrhoea, and any significant changes in mood. You can report suspected side effects directly to the MHRA via the Yellow Card scheme. The side-effect guidance for tirzepatide covers this territory in full.
Your prescriber is the first port of call for anything clinical, a dose that's harder to tolerate than expected, a question about timing, or a new medicine starting that might interact. At nume, aftercare is available seven days a week. Every repeat order is clinically re-reviewed before dispatch, so there's a natural checkpoint built into the process even if nothing goes wrong.
GP notification is part of how responsible prescribing works, the way our service is set up includes informing your GP in line with GPhC guidance, so your primary care record stays current. If you're considering Mounjaro for the first time, the full Mounjaro overview explains the treatment in detail, and our clinical team reviews every consultation personally. Questions that come up between consultations can go to our support team via our contact page.
Cost sometimes comes up at this point too, if you're weighing up the ongoing investment, the context behind recent UK pricing changes is worth reading before making a decision.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.